Characteristics of patients initiating empagliflozin or other non-insulin glucose lowering drugs in the United Kingdom (Empa DUS in UK)

First published 22/08/2016

Last updated 31/03/2024

EU PAS number:

EUPAS14507

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

1245-0122-protocol-2016-08-11_Version 2.0_highlighted_geschwärzt

English (591.2 KB - PDF)View document

Study results

Study results

1245-0122-final-report_redacted_final

English (110.76 KB - PDF)View document

Study report

Other information